שולי רווח נקי ממכירות Moolec Science SA (MLEC)

לוגו גרפי של moolecscience.com (MLEC)

The sales margin ratio helps assess the pricing power of Moolec Science SA (MLEC) within the innovative components segment. Patents and stringent bioengineering controls create a high barrier to entry. Protein production in seeds across the US and South America ensures business stability. The current value of 0.00 expresses the metric level, allowing investors to track operational shifts in real time.

MLEC: שיעור רווח נקי Moolec Science 28.04.2023 - 14.11.2026

פילוחים אנליטיים ודוחות נתונים של חברת moolecscience.com (MLEC)

- שער מניה ותחזית מחירי מומחים:
ניתוח כל מדדי החברה:Moolec Science S.A. - MLEC
סחורת הדגל של Moolec Science SA

Long-term investing requires strict control over asset monetization efficiency. Moolec Science SA (MLEC) is currently transforming production by implementing molecular farming to green food proteins. By analyzing the net profitability of sales, an investor can see the share of final income in total revenue for each trading day. Short-term drawdowns here often reflect R&D capital expenditures rather than business decline. The stability of this metric confirms the viability of the innovative model.